RxDoctor Payments Data

Robert Meek, MD

Otolaryngology · Annapolis, MDNPI 1316035447

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.3% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations.

$6,497in general payments, 2019–2025

Across 191 payments — averaging $34.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurent Medical Limited$1K
  • GSK$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Sanofi$923
  • Optinose US, Inc.$387
  • Inspire Medical Systems, Inc.$325
  • plus $1K from 19 others

What the payments were for

  • Speaking & faculty fees$1482%
  • Food & beverage$6,19195%
  • Education$1582%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,497 in reported general payments places this provider in the 85th percentile of 222 otolaryngology providers in Maryland.

See all otolaryngology providers in Maryland

Medicare billing

Part B allowed, 2024
$721,785
Medicare patients
1,067
Services billed
5,209

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Budesonide85$29,768
Dexlansoprazole DrDexlansoprazole53$17,310
Rabeprazole Sodium195$9,508
Mometasone Furoate52$8,321
Omeprazole394$6,334
Ipratropium Bromide144$5,181
Fluocinolone Acetonide Oil90$3,578
Famotidine252$3,450
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth30$2,681
Azelastine Hcl60$2,387
Amitriptyline Hcl120$2,235
Pregabalin22$1,288
Bethanechol Chloride12$807
Fluticasone Propionate54$676
Methylprednisolone99$583

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →